In lung cancer, the anti-cancer gene miR-320b downregulates the expression of IGF2BP2 and thymidine kinase 1 (TK1), thus suppressing angiogenesis and lung cancer growth (Ma et al., 2021). This evidence concerns the gene IGF2BP2 and lung carcinoma.